Innate Pharma présente ses résultats financiers et l'avancée de son portefeuille au troisième trimestre 2020
November 17, 2020 01:00 ET
|
INNATE PHARMA
Lacutamab a reçu le statut « PRIME » de l’Agence Européenne du Médicament dans le syndrome de SézaryLe démarrage de la Phase 3 de monalizumab déclenche un paiement d’étape de 50 millions de dollars...
Innate Pharma Reports Third Quarter 2020 Financial Results and Business Update
November 17, 2020 01:00 ET
|
INNATE PHARMA
Lacutamab granted PRIME designation in Sézary Syndrome by the European Medicines AgencyMonalizumab Phase 3 study initiated, triggering $50 million milestone paymentCash position of €163.6 million1 as...
Legacy Housing Corporation Reports 2020 Third Quarter Results
November 16, 2020 19:15 ET
|
Legacy Housing Corporation
BEDFORD, Texas, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Legacy Housing Corporation (NASDAQ: LEGH) today announced its financial results for the third quarter ended September 30, 2020. Financial...
VERB Reports Record-Breaking Digital Revenues in 2020 Third Quarter Financial Results
November 16, 2020 16:05 ET
|
Verb Technology Company, Inc.
SaaS recurring revenue up 16% sequentially and 55% year over yearSix consecutive quarters of consistent SaaS recurring revenue growthHighest level of quarterly Digital revenue, up 9% sequentially and...
The Keg Royalties Income Fund Announces Third Quarter 2020 Results
November 12, 2020 17:32 ET
|
The Keg Royalties Income Fund
Not for distribution to U.S. News wire services or dissemination in the U.S. VANCOUVER, British Columbia, Nov. 12, 2020 (GLOBE NEWSWIRE) -- The Keg Royalties Income Fund (the “Fund”)...
Xebec annonce ses résultats financiers du 3e trimestre 2020
November 10, 2020 08:00 ET
|
Xebec Adsorption
- Revenus de 18,4 $M, BAIIA négatif de 1,3 $M et perte nette de 2,2 $M - MONTRÉAL, 10 nov. 2020 (GLOBE NEWSWIRE) -- Xebec Adsorption Inc. (TSXV: XBC) (« Xebec »), fournisseur mondial de...
Xebec Announces Q3 2020 Financial Results
November 10, 2020 08:00 ET
|
Xebec Adsorption
- Revenue of $18.4 million, negative EBITDA of $1.3 million and net loss of $2.2 million - MONTREAL, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Xebec Adsorption Inc. (TSXV: XBC) ("Xebec"), a global...
BioNTech veröffentlicht Ergebnisse des dritten Quartals und Informationen zur Geschäftsentwicklung
November 10, 2020 07:15 ET
|
BioNTech SE
Impfstoffkandidat erwies sich in der ersten Zwischenanalyse als mehr als 90 % wirksam im Schutz vor COVID-19-Erkrankung in Probanden ohne nachweisliche vorangegangene SARS-CoV-2-Infektion In der...
BioNTech Announces Third Quarter 2020 Financial Results and Corporate Progress
November 10, 2020 07:15 ET
|
BioNTech SE
BNT162b2 vaccine candidate was found to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in first interim efficacy analysis from Phase 3...
Smart Sand, Inc. Announces Third Quarter 2020 Results
November 09, 2020 16:30 ET
|
Smart Sand, Inc.
3Q 2020 Revenue of $23.4 million 3Q 2020 total tons sold of approximately 309,000 3Q 2020 Net Income of $36.3 million3Q 2020 Adjusted EBITDA of $6.1 million 3Q 2020 Contribution Margin of $10.4...